Teeccino Is Ready for Explosive Growth
Teeccino, a coffee alternative, has achieved product-market fit and is looking for explosive growth in the coming years.
Profile picture of Teddy Lyons
Analyst Report: Upgrade for access Scripx Offers Another Opportunity in the Virtual Pharmacy Space
Scripx is a Texas-based prescription fulfillment and delivery startup. While not the first in its space, it offers another opportunity to invest in the space.
- Details
- Company: Scripx Pharmacy & Health
- Security Type: SAFE
- Valuation: $12,000,000
- Min Investment: $100
- Platform: Republic
- Deadline: Jan 31, 2023
Francis Vu - November 29th, 2022
Introduction
Compared to only a decade ago, technology has made life far more convenient. Nowadays, I can easily check-in for flights on my phone, have a telehealth visit with my doctor, and have food delivered right to my door. Even highly regulated industries — like prescription medicine — have become easier to access because of technology. The emergence of companies and services like NowRx, Capsule, and others have allowed people to avoid the hassle of going to a pharmacy and waiting in line for their medicine. Instead, they can have prescriptions filled automatically and delivered right to their homes.Â
Scripx is following in the footsteps of NowRx and Capsule. It’s a Dallas-based virtual pharmacy operating within the Dallas-Fort Worth metropolitan area. Scripx offers prescription fulfillment and delivery as well as limited telehealth services. Customers can use the company’s mobile app to upload insurance documents, track their prescriptions, and order refills. But there are a few things investors should consider before investing in a duplicative company like Scripx. Rather than blazing a new trail, it’s following the drug delivery service playbook created by NowRX and Capsule. And that comes with its own mix of advantages and disadvantages.
Pay Annually - save 17%
save 17%
This content requires: Edge
Data-driven startup investment ratings, AI analyst reports, and portfolio company exit and failure tracking
$
15
/month
12.50
/annually
What's included
- Everything in Free plus
- Data-driven investment ratings and AI analyst reports
- Advanced company search table (with ratings and reports)
- Markets page filters and historical industry data
- Startup investment exit and failure tracker
- Startup Portfolio Tracking
- Follows
- Advanced Search Table
- Founder Interviews
- Trending Companies
- Fundraising Analytics
- News and Crowdopedia
Advanced Search table full access, including ratings and analyst reports.
Charts and trends of capital raised by platform, security type, industry, and more.
Unlock Ratings and AI analyst report filters in the Advanced Company Search.
Track IPOs, acquisitions, failures and other exits for companies in your portfolio.
